ABT vs TMDX
Abbott Laboratories · TransMedics Group Inc
Relative return (rebased to 100)
Key stats
| Metric | ABT | TMDX |
|---|---|---|
| Price | $103.36 | $85.04 |
| Market Cap | $180.03B | $2.95B |
| P/E | 27.60 | 15.50 |
| P/B | 3.46 | 5.69 |
| P/S | 4.06 | 4.87 |
| ROE | 12.5% | 36.7% |
| Net Margin | 14.7% | 31.4% |
| Gross Margin | — | 59.9% |
| Revenue Growth | 5.7% | 37.1% |
| Dividend Yield | 2.32% | — |
| EPS | $3.75 | $5.49 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.